Skip to content

Effect of Herbal Unani Medicine on unhealthy levels of one or more kind of lipid (fat) in blood.

Efficacy of Unani formulation in Dyslipidemia- An open labelled interventional clinical trial

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/09/028106
Enrollment
30
Registered
2020-09-28
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E788- Other disorders of lipoprotein metabolism

Interventions

Intervention1: Unani formulation: Test drug will be given orally in a dose of 4.5 grams powder with lukewarm water in morning in an empty stomach. By giving the instruction to patients- NOT to take an

Sponsors

NATIONAL INSTITUE OF UNANI MEDICINE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ï??BMI between 25-35 kg/m2 ï??A) LDL-cholesterol:130-159mg/dl(Borderline high)8 B)Totalcholesterol:200-239mg/dl(Borderline High)8 C)HDL-cholesterol: 60mg/dl(High)8 D)Serum Triglycerides:200-499mg/dl(High)8 Patient who will give consent and able to do follow up.

Exclusion criteria

Exclusion criteria: 1. Patient below the age of 20 years and above the age of 55 years 2. Pregnant and lactating mothers 3. Patient with systemic illness such malignancy, liver, kidney dysfunction, T.B. etc.

Design outcomes

Primary

MeasureTime frame
Effects on TGL, HDL, LDL, VLDL, TC (normal/decrease).Timepoint: 0th day and 42nd day

Secondary

MeasureTime frame
BMI, Waist Circumference, Hip and Waist Ratio, Weight in KgsTimepoint: 0th day, 14th day, 28th day, 42nd days.

Countries

India

Contacts

Public ContactProf Mansoor Ahmed Siddiqui

NATIONAL INSTITUE OF UNANI MEDICINE

mansoorsiddiquidr@gmail.com9448124054

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026